Suven Life Sciences Limited
Suven Life Sciences Limited (SUVEN) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Healthcare Research, Analytics & Technology
suven.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Stock price
₹372.85
Market cap
9,830 Cr
P/B
14.23
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3 Cr | 2 Cr | 2 Cr | 1 Cr | 3 Cr | 2 Cr | 1 Cr | 2 Cr | 0.92 Cr | 3 Cr | 2 Cr | 4 Cr |
| Operating expenses (approx.) | 27 Cr | 49 Cr | 33 Cr | 32 Cr | 55 Cr | 41 Cr | 45 Cr | 53 Cr | 81 Cr | 106 Cr | 52 Cr | 136 Cr |
| EBITDA | -24 Cr | -46 Cr | -30 Cr | -31 Cr | -52 Cr | -39 Cr | -44 Cr | -51 Cr | -80 Cr | -103 Cr | -51 Cr | -133 Cr |
| OPM % | -768.4% | -1884.8% | -1269.8% | -3035.6% | -2029.2% | -2435.3% | -2987.1% | -2718.6% | -8678.3% | -3679.7% | -3330.9% | -3715.9% |
| Other income | 5 Cr | 6 Cr | 4 Cr | 4 Cr | 4 Cr | 2 Cr | 1 Cr | 0.60 Cr | 4 Cr | 3 Cr | 7 Cr | 8 Cr |
| Interest | 0.04 Cr | 0.04 Cr | 0.03 Cr | 0.02 Cr | 0.02 Cr | 0.0079 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0.16 Cr | 0.48 Cr |
| Depreciation | 2 Cr | 2 Cr | 2 Cr | 1 Cr | 1 Cr | 2 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 2 Cr | 2 Cr |
| Profit before tax | -13 Cr | -42 Cr | -28 Cr | -28 Cr | -50 Cr | -39 Cr | -44 Cr | -52 Cr | -77 Cr | -102 Cr | -46 Cr | -128 Cr |
| Tax % | 0.0% | 0.0% | 3.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net profit | -13 Cr | -42 Cr | -27 Cr | -28 Cr | -50 Cr | -39 Cr | -44 Cr | -52 Cr | -77 Cr | -102 Cr | -46 Cr | -128 Cr |
| EPS (₹) | ₹-0.58 | ₹-1.92 | ₹-1.22 | ₹-1.29 | ₹-2.27 | ₹-1.79 | ₹-2.02 | ₹-2.36 | ₹-3.48 | ₹-4.55 | ₹-2.02 | ₹-4.84 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 664 Cr | 14 Cr | 13 Cr | 12 Cr | 14 Cr | 12 Cr | 7 Cr | 7 Cr | Sign in for TTM |
| Operating expenses (approx.) | 503 Cr | 130 Cr | 94 Cr | 134 Cr | 139 Cr | 140 Cr | 172 Cr | 292 Cr | Sign in for TTM |
| EBITDA | 160 Cr | -116 Cr | -80 Cr | -122 Cr | -126 Cr | -128 Cr | -166 Cr | -285 Cr | Sign in for TTM |
| OPM % | 24.2% | -802.8% | -594.0% | -1033.3% | -929.8% | -1094.7% | -2490.7% | -3998.8% | Sign in for TTM |
| Other income | 24 Cr | 14 Cr | 8 Cr | 5 Cr | 8 Cr | 21 Cr | 11 Cr | 14 Cr | Sign in for TTM |
| Interest | 4 Cr | 0.55 Cr | 0.82 Cr | 0.53 Cr | 0.29 Cr | 0.16 Cr | 0.05 Cr | 0.16 Cr | Sign in for TTM |
| Depreciation | 22 Cr | 4 Cr | 4 Cr | 4 Cr | 7 Cr | 7 Cr | 6 Cr | 6 Cr | Sign in for TTM |
| Profit before tax | 159 Cr | -106 Cr | -77 Cr | -122 Cr | -118 Cr | -106 Cr | -161 Cr | -276 Cr | Sign in for TTM |
| Tax % | 45.2% | 11.5% | 6.9% | 0.0% | 0.0% | 0.9% | 0.0% | 0.0% | Sign in for TTM |
| Net profit | 87 Cr | -94 Cr | -72 Cr | -122 Cr | -118 Cr | -105 Cr | -161 Cr | -276 Cr | Sign in for TTM |
| EPS (₹) | ₹6.83 | ₹-2.01 | ₹-5.67 | ₹-9.57 | ₹-6.63 | ₹-4.82 | ₹-7.37 | ₹-12.13 | Sign in for TTM |
| Dividend payout % | — | — | — | — | — | — | — | — | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 13 Cr | 13 Cr | 13 Cr | 15 Cr | 22 Cr | 22 Cr | 22 Cr | 26 Cr |
| Reserves | 818 Cr | 131 Cr | 95 Cr | 82 Cr | 354 Cr | 248 Cr | 88 Cr | 565 Cr |
| Borrowings | 37 Cr | 1 Cr | 0.39 Cr | 0.48 Cr | — | — | — | — |
| Other liabilities | 171 Cr | 37 Cr | 20 Cr | 11 Cr | 14 Cr | 15 Cr | 25 Cr | 33 Cr |
| Total liabilities | 1,039 Cr | 182 Cr | 128 Cr | 108 Cr | 389 Cr | 285 Cr | 135 Cr | 624 Cr |
| Fixed assets (net) | 291 Cr | 21 Cr | 18 Cr | 35 Cr | 36 Cr | 27 Cr | 59 Cr | 56 Cr |
| CWIP | 111 Cr | — | 5 Cr | 4 Cr | 0 Cr | 0 Cr | 0.0097 Cr | 4 Cr |
| Investments | 230 Cr | 0.05 Cr | 0.09 Cr | 45 Cr | 46 Cr | 76 Cr | 22 Cr | 0 Cr |
| Loans & advances | 0.11 Cr | 42 Cr | 41 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | 157 Cr | 0 Cr | 0.14 Cr | 0.02 Cr | 0 Cr | 0.71 Cr | 0.24 Cr | 0.10 Cr |
| Trade receivables | 150 Cr | 2 Cr | 2 Cr | 1 Cr | 0.81 Cr | 1 Cr | 1 Cr | 2 Cr |
| Cash & bank | 11 Cr | 15 Cr | 9 Cr | 5 Cr | 37 Cr | 15 Cr | 15 Cr | 8 Cr |
| Other assets | 89 Cr | 102 Cr | 53 Cr | 18 Cr | 269 Cr | 165 Cr | 37 Cr | 555 Cr |
| Total assets | 1,039 Cr | 182 Cr | 128 Cr | 108 Cr | 389 Cr | 285 Cr | 135 Cr | 624 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | -128 Cr | -208 Cr | -83 Cr | -154 Cr | -302 Cr |
| Cash from investing | — | — | — | -22 Cr | -156 Cr | 62 Cr | 155 Cr | -462 Cr |
| Cash from financing | — | — | — | 146 Cr | 396 Cr | -1 Cr | -0.76 Cr | 757 Cr |
| Net cash flow | — | — | — | -4 Cr | 32 Cr | -22 Cr | 0.09 Cr | -7 Cr |
| Free cash flow (OCF − Capex) | — | — | — | -147 Cr | -211 Cr | -83 Cr | -191 Cr | -307 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 19.6% | -73.3% | -70.7% | -125.7% | -31.4% | -39.2% | -146.1% | -46.7% |
| ROE % | 10.5% | -65.7% | 0.0% | 0.0% | 0.0% | -38.9% | -146.1% | -46.7% |
| Debtor days | 82 | 57 | 48 | 40 | 22 | 40 | 73 | 77 |
| Inventory days | 280 | 0 | 4 | 1 | 0 | 22 | 13 | 5 |
| Days payable | 108 | 146 | 81 | 61 | 45 | 65 | 286 | 246 |
| Cash conversion cycle | 254 | -89 | -29 | -20 | -23 | -2 | -200 | -164 |
| Debt / equity | 0.04 | 0.0076 | 0.0036 | 0.0050 | — | — | — | — |
| Current ratio | 4.18 | 2.49 | 6.45 | 8.01 | 22.61 | 18.99 | 3.21 | 17.69 |
| Net debt / EBITDA | 0.00 | — | — | — | — | — | — | — |
Compare with peers
Loading peers…